Archives20242023202220212020201920182017201620152014201320122011 May 07, 2015Notice of Annual General Meeting: 29 May 2015 Read More April 30, 2015Preliminary Results Announcement for the year ended 31 December 2014 Read More April 30, 2015Dr Stéphane Méry Appointed as Non-Executive Director Read More February 11, 2015Cancer Update: IPP-204106 Read More January 27, 2015Advance Assurance Received from H M Revenue and Customs Regarding “Enterprise Investment Scheme” Status Read More January 22, 2015Landmark Collaboration Agreement & Commencement of Pivotal Phase III Lupuzor™ Study with Simbec-Orion Read More October 21, 2014ImmuPharma awarded €400,000 grant in support of its pioneering research in the Bordeaux region of France Read More October 21, 2014AVIVA lead investor in £3.4 million fund raising to support Lupuzor™ Pivotal Phase III Progress Read More October 02, 2014INTERIM RESULTS ANNOUNCEMENT for the six months ended 30 June 2014 Read More October 02, 2014Lupuzor™ Gears Up To Start Pivotal Phase III trials Read More June 27, 2014ANNUAL GENERAL MEETING: 2014 Read More June 27, 2014ImmuPharma to access pioneering research in the Bordeaux region of France Read More 1…1718192021
January 27, 2015Advance Assurance Received from H M Revenue and Customs Regarding “Enterprise Investment Scheme” Status Read More
January 22, 2015Landmark Collaboration Agreement & Commencement of Pivotal Phase III Lupuzor™ Study with Simbec-Orion Read More
October 21, 2014ImmuPharma awarded €400,000 grant in support of its pioneering research in the Bordeaux region of France Read More
October 21, 2014AVIVA lead investor in £3.4 million fund raising to support Lupuzor™ Pivotal Phase III Progress Read More